Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
31.07.2013 23:48:00

Medbox Clients Lead the Way with Favorable Arizona Legal Ruling

HOLLYWOOD, Calif., July 31, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced that its Arizona dispensary clients were just granted more time than initially allowed by state regulations to get their dispensaries up and running. Medbox's clients are lead plaintiffs in an injunction suit seeking extra time to open given legal and political challenges to the implementation of Arizona's Medical Marijuana Act.  Other dispensaries later joined in the suit. Judge Randall Warner's ruling granting the plaintiffs' injunction request requires the Arizona Department of Health Services to renew the dispensaries' certificates for another year, and make new rules allowing dispensaries to apply to the agency for more time if needed, instead of coming back to Court.

"We knew our clients had been working hard to get their dispensaries open and operating, but some met with greater resistance than others in their local jurisdictions. Once we saw that problem unfolding, our instinct was to come to the aid of those clients who needed extra help. Our clients led the way in the injunction suit to get the state regulations changed," stated Vincent Mehdizadeh, Chief Operations Officer of Medbox, Inc. "We respect the work that ADHS did in making its rules initially. It became clear to us though that there were things that ADHS simply could not foresee.  Holding diligent dispensary operators to a strict one-year time frame to get local jurisdiction approval was simply an undue burden on them. Going to court was the only way to get the legal relief that some of our clients needed."

Medbox was involved in Arizona's program at its very early stages, and submitted comments to ADHS during the rulemaking process.

"One of the things that distinguishes Medbox has been its commitment to the whole process from the agency rulemaking stage to helping clients get open and operating," Dr. Bruce Bedrick, Medbox CEO stated. "We are very pleased by Judge Warner's ruling and are gratified that it will help our clients move closer to their goals."  

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws.  Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control.  In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change.  Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation.  We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

SOURCE Medbox, Inc.

Nachrichten zu Medbox Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Medbox Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!